Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ACR Makes Changes to Adult, Pediatric Vaccinations Guidance ACR Makes Changes to Adult, Pediatric Vaccinations Guidance
The pneumococcal, recombinant zoster, and HPV vaccines are among those recommended for patients taking immunosuppressive medications.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 8, 2022 Category: Internal Medicine Tags: Rheumatology News Source Type: news

Post-Zoster Vaccine Flares Not Increased in Patients With IMIDs Post-Zoster Vaccine Flares Not Increased in Patients With IMIDs
Flares were defined as hospitalization/emergency department visits for IMIDs, steroid treatment with a short-acting oral glucocorticoid, or treatment with a parenteral glucocorticoid injection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Shingles Risk Increased For People Over 50 Who Had COVID, Study Says
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p25").init({"mcp":"cbs","width":"100%","height":"100%","video":"6228464","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p25","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5","customMetadata":{"vi...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 20, 2022 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News COVID-19 Covid-19 Boston, MA Health Healthwatch Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Shingles Source Type: news

Use of RZV in Immunocompromised Adults Aged > 19 Years Use of RZV in Immunocompromised Adults Aged > 19 Years
Recombinant zoster vaccine is the first herpes zoster vaccine approved for use in immunocompromised persons. Review its use in this population in this brief article.Morbidity & Mortality Weekly Report (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 11, 2022 Category: Transplant Surgery Tags: Public Health & Prevention Journal Article Source Type: news

Safety of Recombinant Zoster Vaccine in Rheumatology Patients Safety of Recombinant Zoster Vaccine in Rheumatology Patients
Is the recombinant zoster vaccine safe to use in rheumatology patients taking immunosuppressive medications?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

ACIP Issues Adult Vaccination Schedule 2022 ACIP Issues Adult Vaccination Schedule 2022
Changes affect zoster, pneumococcal, and hepatitis B vaccines, and COVID-19 is now included.News Alerts (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Alert Source Type: news

Herpes Zoster Vaccine Can Save Your Patients' Eyesight Herpes Zoster Vaccine Can Save Your Patients' Eyesight
Herpes zoster ophthalmicus can be devastating. Dr Rapuano urges all ophthalmologists to discuss the zoster vaccine with their patients.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2022 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Recommendations Updated for Recombinant Zoster Vaccine
THURSDAY, Jan. 20, 2022 -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2022 Category: Pharmaceuticals Source Type: news

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Adult Health Adult Vaccinations Advisory Committee on Immunization Practices (ACIP) MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Source Type: news

Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring and painful disease that impacts about one in three people in the United States during their lifetime. (Source: World Pharma News)
Source: World Pharma News - January 6, 2022 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Study: Shingrix shingles vaccine riskier for Guillain-Barr é than older shot
Older adults who receive the Shingrix shingles vaccines are more than twice as likely to develop Guillain-Barr é syndrome compared with those given the older Zostavax product, a JAMA Internal Medicine study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 1, 2021 Category: Consumer Health News Source Type: news

Shingles vaccine could be a game-changer for arthritis and other disorders - major study
NEW RESEARCH has found a vaccine containing live shingles, or varicella-zoster, is a safe and effective treatment for people living with inflammatory disorders, who are at a higher risk of developing shingles. (Source: Daily Express - Health)
Source: Daily Express - Health - September 28, 2021 Category: Consumer Health News Source Type: news

CDC: Advisory Committee on Immunization Practices (ACIP)
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on September 29-30, 2021. The agenda will include discussions on cholera vaccine, hepatitis vaccines, herpes zoster vaccines, orthopoxvirus vaccine, pneumococcal vaccine, and tickborne encephalitis vaccine. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required and the meeting is open to the public, available online via a live webcast. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 26, 2021 Category: Rural Health Source Type: news

Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults
Philadelphia, London -- 26 July 2021 -- GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 26, 2021 Category: Drugs & Pharmacology Source Type: news

Herpes zoster (shingles) immunisation programme 2020 to 2021: evaluation reports, PHE (updated 5th July 2021)
This report evaluates the seventh year of the shingles vaccination programme which offers the shingles vaccine to those turning 70 and 78 years old respectively. Adults remain eligible until their 80th birthday. 5 July 2021 Updated main report. 21 June 2021 Updated report to correct an error in data from one GP IT supplier. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 6, 2021 Category: Consumer Health News Source Type: news